A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors

NCT06063681 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced / Metastatic Solid Tumor

Interventions

DRUG: SR-8541A
DRUG: Immune checkpoint inhibitor (ICI)

Sponsor

Stingray Therapeutics